<bill session="105" type="h" number="2407" updated="2013-07-14T18:50:29-04:00">
  <state datetime="1997-09-04">REFERRED</state>
  <status>
    <introduced datetime="1997-09-04"/>
  </status>
  <introduced datetime="1997-09-04"/>
  <titles>
    <title as="introduced" type="short">Office of National Drug Control Policy Reauthorization Act of 1997</title>
    <title as="introduced" type="official">To reauthorize the Office of National Drug Control Policy, and for other purposes.</title>
  </titles>
  <sponsor id="400238"/>
  <cosponsors>
    <cosponsor id="400553" joined="1997-09-04"/>
    <cosponsor id="400518" joined="1997-09-04"/>
    <cosponsor id="400090" joined="1997-09-04"/>
    <cosponsor id="400234" joined="1997-09-04"/>
    <cosponsor id="400332" joined="1997-09-04"/>
    <cosponsor id="400333" joined="1997-09-04"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1997-09-04">
      <text>Referred to the Committee on Government Reform and Oversight, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="1997-09-04">
      <text>Referred to House Government Reform and Oversight</text>
    </action>
    <action datetime="1997-09-04">
      <text>Referred to House Commerce</text>
    </action>
    <action datetime="1997-09-11">
      <text>Referred to the Subcommittee on National Security, International Affairs and Criminal Justice.</text>
      <committee name="House Government Reform and Oversight"/>
    </action>
    <action datetime="1997-09-19">
      <text>Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.</text>
      <committee name="House Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSGO" name="House Government Reform and Oversight" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSGO06" subcommittee="National Security, International Affairs and Criminal Justice" name="House Government Reform and Oversight"/>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Drug abuse"/>
    <term name="Alcohol and youth"/>
    <term name="Armed forces and national security"/>
    <term name="Authorization"/>
    <term name="Civil-military relations"/>
    <term name="Congress"/>
    <term name="Congressional elections"/>
    <term name="Congressional reporting requirements"/>
    <term name="Crime and law enforcement"/>
    <term name="Drug abuse prevention"/>
    <term name="Drug law enforcement"/>
    <term name="Drug policy"/>
    <term name="Drug traffic"/>
    <term name="Economics and public finance"/>
    <term name="Executive Office of the President"/>
    <term name="Families"/>
    <term name="Federal officials"/>
    <term name="Gifts"/>
    <term name="Government employees' political activities"/>
    <term name="Government operations and politics"/>
    <term name="Government trust funds"/>
    <term name="Intergovernmental relations"/>
    <term name="Performance measurement"/>
    <term name="Planning-programming-budgeting"/>
    <term name="Presidential appointments"/>
    <term name="Presidential elections"/>
    <term name="Science, technology, communications"/>
    <term name="Smoking and youth"/>
    <term name="Technology assessment"/>
  </subjects>
  <amendments/>
  <summary>9/4/1997--Introduced.
Office of National Drug Control Policy Reauthorization Act of 1997 - Amends the National Narcotics Leadership Act of 1988 (the Act) to revise definitions, including by: (1) including within the definition of "demand reduction" activities to reduce the underage use of tobacco or alcoholic beverages; and (2) defining "intergovernmental relations" as domestic activities conducted by a National Drug Control Program agency that are intended to reduce the availability and use of drugs. Modifies provisions of the Act regarding establishment of the Office of National Drug Control Policy (the Office) to: (1) set forth the responsibilities of such Office (to develop national drug control policy, coordinate and oversee its implementation, assess and certify the adequacy of national drug control programs and budgets, and evaluate their effectiveness); and (2) provide for Deputy Directors of National Drug Control Policy, for International Drug Policy, and for Intergovernmental Relations. Establishes in the Treasury a fund for the receipt of gifts to aid or facilitate the work of the Office. Prohibits Federal officers in the Office from participating in Federal election campaign activities, except for making contributions to individual campaigns. Sets forth or modifies provisions regarding the responsibilities of national drug control program agencies, the drug certification process, and coordination with executive branch departments and agencies in supply and demand reduction and intergovernmental relations. Amends provisions regarding the National Drug Control Strategy to require: (1) the President to submit to the Congress by February 1, 1997, a Strategy which sets forth a comprehensive ten-year plan for reducing drug abuse and its consequences in the United States by limiting the availability of and reducing the demand for illegal drugs and the first of annual reports on progress in implementing the Strategy; and (2) the Director of National Drug Control Policy to include with the annual Strategy Report a description of the national drug control performance measurement system. Establishes in the Office a High Intensity Drug Trafficking Areas Program. Amends provisions regarding the Counter-Drug Technology Assessment Center to have it headed by a Director of Technology and to specify duties of such Director, such as identifying demand reduction basic and applied research needs and initiatives. Requires the Departments of Defense and Health and Human Services to render assistance and support to the Office and its Director in the conduct of counter-drug technology assessment. Terminates the Office on September 30, 2009. Authorizes appropriations.</summary>
</bill>
